Jialiang Liang, Ph.D.

Healthcare analyst at AB Arya

Jialiang Liang, Ph.D.

Jialiang Liang, Ph.D. is a healthcare analyst at AB Arya and a Vice President at AllianceBernstein in New York.1 He has over 10 years of experience in the finance and research fields.

Professional Experience

Vice President, Healthcare L/S Analyst AllianceBernstein September 2023 - Present1
Vice President J.P. Morgan January 2023 - September 20231
Equity Research Associate J.P. Morgan September 2021 - January 20231
Associate Director UBS August 2020 - September 20211
Equity Research Associate Citizens JMP Securities, LLC September 2019 - July 20201
Postdoctoral Associate Massachusetts Institute of Technology March 2017 - August 20191

Education

Doctor of Philosophy (PhD), Biomedical Science Icahn School of Medicine at Mount Sinai 2010 - 20171
Master of Science (M.S.), Stem cell biology University of Chinese Academy of Sciences 2007 - 20101
Bachelor of Science (B.S.), Biology Xiamen University 2003 - 20071

Liang is proficient in Cantonese, Mandarin, and English.1 He holds several financial licenses including Series 63, 86, 87, and SIE.1

Experience

Vice President at AllianceBernstein since September 2023

Vice President at J.P. Morgan (January 2023 - September 2023), Equity Research Associate at J.P. Morgan (September 2021 - January 2023), Associate Director at UBS (August 2020 - September 2021), Equity Research Associate at Citizens JMP Securities, LLC (September 2019 - July 2020), Postdoctoral Associate at Massachusetts Institute of Technology (March 2017 - August 2019)

Education

Doctor of Philosophy (PhD) in Biomedical Science from Icahn School of Medicine at Mount Sinai (2010 - 2017), Master of Science (M.S.) in Stem Cell Biology from University of Chinese Academy of Sciences (2007 - 2010), Bachelor of Science (B.S.) in Biology from Xiamen University (2003 - 2007)